Atrial fibrosis is a strong marker of AF risk, and a direct effect of fibrosis on AF risk has been demonstrated in a mouse model of TGF-β over-activity (Verheule et al., 2004). This evidence concerns the gene TGFB1 and atrial fibrillation.